| scholarly article | Q13442814 |
| P50 | author | Ornella Parolini | Q51574670 |
| P2093 | author name string | Alice Masserdotti | |
| Andrea Papait | |||
| Antonietta R Silini | |||
| P2860 | cites work | A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis. | Q51126781 |
| Human placenta-derived cells have mesenchymal stem/progenitor cell potential. | Q52087798 | ||
| Phenotypic and functional characterization of mesenchymal stem cells from chorionic villi of human term placenta. | Q54308278 | ||
| Engraftment potential of human amnion and chorion cells derived from term placenta. | Q54689348 | ||
| Comparison of the Biological Characteristics of Mesenchymal Stem Cells Derived from the Human Placenta and Umbilical Cord. | Q55275337 | ||
| Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach. | Q55387791 | ||
| Immunomodulatory placental-expanded, mesenchymal stromal cells improve muscle function following hip arthroplasty | Q56972323 | ||
| Mesenchymal stem cells in human placental chorionic villi reside in a vascular Niche | Q57670075 | ||
| Therapeutic potential of products derived from mesenchymal stem/stromal cells in pulmonary disease | Q58570616 | ||
| Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning | Q60046871 | ||
| Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers | Q60634398 | ||
| The Expression of CD68 in Human Umbilical Cord Mesenchymal Stem Cells: New Evidences of Presence in Non-Myeloid Cell Types | Q60634406 | ||
| Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide | Q61645540 | ||
| Stem Cells Derived from Human Fetal Membranes Display Multilineage Differentiation Potential | Q61847018 | ||
| How far are we from the clinical use of placental-derived mesenchymal stem cells? | Q63197008 | ||
| Antibacterial properties of human amnion and chorion in vitro | Q73412006 | ||
| Chorioamniotic membranes constitute a competent barrier to group b streptococcus in vitro | Q77953822 | ||
| Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta | Q81096492 | ||
| Amnion and chorion cells as therapeutic agents for transplantation and tissue regeneration: a field in its infancy | Q81145426 | ||
| Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities | Q81364711 | ||
| Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta | Q81529154 | ||
| A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1 | Q81596726 | ||
| Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration | Q82754466 | ||
| The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells | Q83574104 | ||
| Conditioned medium from amniotic membrane-derived cells prevents lung fibrosis and preserves blood gas exchanges in bleomycin-injured mice-specificity of the effects and insights into possible mechanisms | Q86453404 | ||
| Therapeutic effect of human amniotic membrane-derived cells on experimental arthritis and other inflammatory disorders | Q87248616 | ||
| The Immunomodulatory Properties of Amniotic Cells: The Two Sides of the Coin | Q88122166 | ||
| Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities | Q88957419 | ||
| Conditioned media derived from mesenchymal stem cell cultures: The next generation for regenerative medicine | Q91049313 | ||
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| Characterization of the conditioned medium from amniotic membrane cells: prostaglandins as key effectors of its immunomodulatory activity | Q28484341 | ||
| Extracellular vesicles: exosomes, microvesicles, and friends | Q29618137 | ||
| Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli | Q29618769 | ||
| International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials | Q30488740 | ||
| Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant crohn's disease: a phase 1 study | Q34749491 | ||
| The MSC: an injury drugstore | Q35130445 | ||
| Conditioned medium from amniotic mesenchymal tissue cells reduces progression of bleomycin-induced lung fibrosis | Q35755955 | ||
| Current View on Osteogenic Differentiation Potential of Mesenchymal Stromal Cells Derived from Placental Tissues | Q35825031 | ||
| Wharton's jelly-derived cells are a primitive stromal cell population | Q35849157 | ||
| How mesenchymal stem cells interact with tissue immune responses | Q36141205 | ||
| Phenotypic and Functional Characterization of Mesenchymal Stem/Multipotent Stromal Cells from Decidua Basalis of Human Term Placenta | Q36610567 | ||
| Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells | Q36987698 | ||
| Mesenchymal stromal cell characteristics vary depending on their origin | Q37190239 | ||
| Soluble factors of amnion-derived cells in treatment of inflammatory and fibrotic pathologies | Q38070020 | ||
| Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine | Q38608414 | ||
| Oxidative stress in mesenchymal stem cell senescence: regulation by coding and non-coding RNAs | Q38648719 | ||
| Is Immune Modulation the Mechanism Underlying the Beneficial Effects of Amniotic Cells and Their Derivatives in Regenerative Medicine? | Q39034662 | ||
| A controlled study of amniotic membrane transplantation for acute Pseudomonas keratitis | Q39246502 | ||
| The dichotomy of placenta-derived cells in cancer growth. | Q39330852 | ||
| Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study | Q40321403 | ||
| Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo | Q40662801 | ||
| Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study. | Q41310202 | ||
| Placenta-derived mesenchymal-like cells (PDA-001) as therapy for chronic pulmonary sarcoidosis: a phase 1 study. | Q41478153 | ||
| Amniotic membrane mesenchymal cells-derived factors skew T cell polarization toward Treg and downregulate Th1 and Th17 cells subsets | Q41518676 | ||
| The challenge of defining mesenchymal stromal cell potency assays and their potential use as release criteria | Q41576464 | ||
| Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy | Q41831728 | ||
| The novel antimicrobial peptide beta3-defensin is produced by the amnion: a possible role of the fetal membranes in innate immunity of the amniotic cavity | Q42470622 | ||
| Antimicrobial Peptides Secreted From Human Cryopreserved Viable Amniotic Membrane Contribute to its Antibacterial Activity | Q42652970 | ||
| Isolation and characterization of true mesenchymal stem cells derived from human term decidua capable of multilineage differentiation into all 3 embryonic layers | Q44782196 | ||
| Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohn's Disease: A Phase 1b/2a Study | Q45013680 | ||
| Fetal mesenchymal stromal cells from cryopreserved human chorionic villi: cytogenetic and molecular analysis of genome stability in long-term cultures | Q45244057 | ||
| Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. | Q46670167 | ||
| Isolation and characterization of mesenchymal cells from human fetal membranes | Q46882275 | ||
| Mesenchymal Stem Cells: Time to Change the Name! | Q47094268 | ||
| Protection of Brain Injury by Amniotic Mesenchymal Stromal Cell-Secreted Metabolites. | Q48475882 | ||
| The first decade of advanced cell therapy clinical trials using perinatal cells (2005-2015). | Q50009004 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biotechnology | Q7108 |
| bioengineering | Q580689 | ||
| regenerative medicine | Q1061415 | ||
| Amniotic Membrane | Q63268039 | ||
| immunomodulation | Q27788458 | ||
| P304 | page(s) | 75 | |
| P577 | publication date | 2019-04-10 | |
| P1433 | published in | Frontiers in Bioengineering and Biotechnology | Q21971197 |
| P1476 | title | Shaping the Future of Perinatal Cells: Lessons From the Past and Interpretations of the Present | |
| P478 | volume | 7 |
Search more.